Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-03-15 @ 4:32 PM
Study NCT ID:
NCT03190733
Status:
UNKNOWN
Last Update Posted:
2017-06-19
First Post:
2017-06-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT
Sponsor:
Zhujiang Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2016-XYNK-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None